Research milestones and news from ORGANOPlus.
CEO Jaeyoung Shin Leads ORGANOPlus to Redefine Drug Development with Human Organoid Chip Platforms
ORGANOPlus, founded by CEO Jaeyoung Shin, is pioneering organoid chip platforms that replicate complex human microenvironments with unmatched precision. Its flagship technologies—VILLIORGAN™ (gut organoid chip) and CANORGAN™ (tumor…
Harvard Medical School and ORGANOPlus Join Forces to Advance Next-Generation IBD Organoid Chip Models
ORGANOPlus signed an MOU with Harvard Medical School to co-develop intestinal muscle–integrated IBD organoid chip models. The partnership combines Harvard’s bio-printed muscle expertise with ORGANOPlus’s VILLIORGAN™ platform to…
